Assignee
UNIV SAITAMA MEDICAL
JP·21 granted patents·13 pending applications·27 citations·filing 2009–2023
Top patents by PatentIndex Score
34 records- 0193US10428148B2Anti-ALK2 antibodyUNIV SAITAMA MEDICAL·Filed 2016·Granted Oct 1, 2019·21 cites·12 claims
- 0282US11293924B2Immunological biomarker for predicting clinical effect of cancerUNIV SAITAMA MEDICAL·Filed 2018·Granted Apr 5, 2022·3 cites·9 claims
- 0372US9873920B2Method for evaluating side-effect onset risk in anticancer drug treatment, including detecting MUC4 gene polymorphismUNIV SAITAMA MEDICAL·Filed 2014·Granted Jan 23, 2018·1 cites·8 claims
- 0472US2023349909A1Immunological biomarker for predicting clinical effect of cancer immunotherapyUNIV SAITAMA MEDICAL·Filed 2023·Application pending·0 cites
- 0570US12298311B2Immunological biomarker for predicting clinical effect of cancerUNIV SAITAMA MEDICAL·Filed 2022·Granted May 13, 2025·0 cites·6 claims
- 0668US11447554B2Anti-ALK2 antibodyUNIV SAITAMA MEDICAL·Filed 2021·Granted Sep 20, 2022·0 cites·27 claims
- 0767US9521953B2Measurement device and measurement methodUNIV SAITAMA MEDICAL·Filed 2013·Granted Dec 20, 2016·2 cites·12 claims
- 0865US2011091886A1Method of distinguishing inflammatory pathogen causing acute respiratory infectionUNIV SAITAMA MEDICAL·Filed 2009·Application pending·0 cites
- 0964US9284557B2Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancerUNIV SAITAMA MEDICAL·Filed 2014·Granted Mar 15, 2016·0 cites·4 claims
- 1063US11312776B2Anti-ALK2 antibodyUNIV SAITAMA MEDICAL·Filed 2019·Granted Apr 26, 2022·0 cites·9 claims
- 1163US2025135226A1Uterine cervical cancer radiotherapy support system, uterine cervical cancer radiotherapy support method, and non-transitory computer-readable recording medium storing uterine cervical cancer radiotherapy support programUNIV SAITAMA MEDICAL·Filed 2023·Application pending·0 cites
- 1259US2013252241A1Method of distinguishing inflammatory pathogen causing acute respiratory infectionUNIV SAITAMA MEDICAL·Filed 2013·Application pending·0 cites
- 1358US10835551B2Double-stranded nucleic acid molecule, DNA, vector, cancer cell growth inhibitor, cancer cell migration inhibitor, and drugUNIV SAITAMA MEDICAL·Filed 2020·Granted Nov 17, 2020·0 cites·10 claims
- 1455US2022223239A1Determination device, determination method, and determination programUNIV SAITAMA MEDICAL·Filed 2020·Application pending·0 cites
- 1555US2024148736A1Combination drug for treating renal cancer and potentiator for therapeutic effects of tyrosine kinase inhibitorUNIV SAITAMA MEDICAL·Filed 2021·Application pending·0 cites
- 1654US2024108275A1Analysis system, analysis method, analytical data acquisition device, and analysis programUNIV SAITAMA MEDICAL·Filed 2021·Application pending·0 cites
- 1753US10851342B2Method for producing pluripotent stem cellsUNIV SAITAMA MEDICAL·Filed 2017·Granted Dec 1, 2020·0 cites·7 claims
- 1850US10561679B2Double-stranded nucleic acid molecule, DNA, vector, cancer cell growth inhibitor, cancer cell migration inhibitor, and drugUNIV SAITAMA MEDICAL·Filed 2015·Granted Feb 18, 2020·0 cites·10 claims
- 1949US9868934B2Method for producing pluripotent stem cellsUNIV SAITAMA MEDICAL·Filed 2013·Granted Jan 16, 2018·0 cites·14 claims
- 2048US9856304B2Peptide and application thereofUNIV SAITAMA MEDICAL·Filed 2014·Granted Jan 2, 2018·0 cites·6 claims
- 2147US10809200B2Test object visualizing deviceUNIV SAITAMA MEDICAL·Filed 2017·Granted Oct 20, 2020·0 cites·7 claims
- 2247US9814785B2Hepatitis C virus liposome vaccineUNIV SAITAMA MEDICAL·Filed 2015·Granted Nov 14, 2017·0 cites·14 claims
- 2347US2024264158A1Biomarker for predicting response to cancer treatmentUNIV SAITAMA MEDICAL·Filed 2021·Application pending·0 cites
- 2446US10369218B2Immunostimulator and method for producing the sameUNIV SAITAMA MEDICAL·Filed 2016·Granted Aug 6, 2019·0 cites·4 claims
- 2546US2019189260A1Method of evaluating therapeutic effect of drug in cancer patient, method of generating evaluation data of therapeutic effect, therapeutic effect evaluation device, and therapeutic effect evaluation programUNIV SAITAMA MEDICAL·Filed 2017·Application pending·0 cites
- 2646US2022267453A1Antibody recognizing extracellular region of alk2/acvr1UNIV SAITAMA MEDICAL·Filed 2020·Application pending·0 cites
- 2744US12442820B2Peripheral blood biomarker for evaluating anti-tumor immune effect of radiation therapyUNIV SAITAMA MEDICAL·Filed 2020·Granted Oct 14, 2025·0 cites·18 claims
- 2842US11859006B2Method of treating ectopic ossification or diffuse intrinsic pontine glioma in a subject by administering an anti-ALK2 antibodyUNIV SAITAMA MEDICAL·Filed 2019·Granted Jan 2, 2024·0 cites·19 claims
- 2942US9612449B2Axially symmetric polarization conversion elementUNIV SAITAMA MEDICAL·Filed 2013·Granted Apr 4, 2017·0 cites·11 claims
- 3041US2022096552A1Method and composition for predicting long-term survival in cancer immunotherapyUNIV SAITAMA MEDICAL·Filed 2020·Application pending·0 cites
- 3140US2015140661A1Method for producing pancreatic hormone-producing cell, pancreatic hormone-producing cell, and differentiation/induction promoterUNIV SAITAMA MEDICAL·Filed 2013·Application pending·0 cites
- 3239US10370730B2Detection method for mutation in 93rd amino acid of hepatitis C virus NS5A protein, and detection kit for mutation in 93rd amino acid of hepatitis C virus NS54 proteinUNIV SAITAMA MEDICAL·Filed 2014·Granted Aug 6, 2019·0 cites·20 claims
- 3335US12159401B2Estimator learning device, estimator learning method, and estimator learning programUNIV SAITAMA MEDICAL·Filed 2020·Granted Dec 3, 2024·0 cites·7 claims
- 3434US2013011921A1Method for production of artificial pluripotent stem cellUNIV SAITAMA MEDICAL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when UNIV SAITAMA MEDICAL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →